TREATMENT OF FGG RELATED HEARING DISORDERS

Disclosed herein are compositions comprising an oligonucleotide that targets FGG. The oligonucleotide may include a small interfering RNA (siRNA) or an antisense oligonucleotide (ASO). Also provided herein are methods of treating a hearing disorder related to FGG. The method may include providing an...

Full description

Saved in:
Bibliographic Details
Main Authors CAJES, Brian, VEKICH, John, MCINNES, Gregory, BRUSE, Shannon, GOTTESMAN, Omri, BUSS, Eric, ROZEMA, David, WAKEFIELD, Darren H, LEWIS, David
Format Patent
LanguageEnglish
French
Published 03.10.2024
Online AccessGet full text

Cover

More Information
Summary:Disclosed herein are compositions comprising an oligonucleotide that targets FGG. The oligonucleotide may include a small interfering RNA (siRNA) or an antisense oligonucleotide (ASO). Also provided herein are methods of treating a hearing disorder related to FGG. The method may include providing an oligonucleotide to a subject that targets FGG. L'invention concerne des compositions comprenant un oligonucléotide qui cible FGG. L'oligonucléotide peut comprendre un petit ARN interférent (ARNsi) ou un oligonucléotide antisens (ASO). L'invention concerne également des procédés de traitement d'un trouble auditif associé à FGG. Le procédé peut comprendre la fourniture d'un oligonucléotide à un sujet qui cible FGG.
Bibliography:Application Number: WO2024US22037